Compare INMD & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INMD | STAA |
|---|---|---|
| Founded | 2008 | 1982 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 842.0M | 867.9M |
| IPO Year | 2018 | 1995 |
| Metric | INMD | STAA |
|---|---|---|
| Price | $13.97 | $26.84 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $17.33 | ★ $22.81 |
| AVG Volume (30 Days) | 653.9K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $1.74 | $30.82 |
| Revenue Next Year | $3.26 | $8.41 |
| P/E Ratio | $10.11 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.72 | $15.59 |
| 52 Week High | $16.74 | $30.81 |
| Indicator | INMD | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 47.19 | 61.78 |
| Support Level | $13.32 | $26.54 |
| Resistance Level | $14.70 | $27.27 |
| Average True Range (ATR) | 0.30 | 1.07 |
| MACD | -0.07 | -0.10 |
| Stochastic Oscillator | 47.95 | 63.16 |
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.